Cue Biopharma, . vs Gilboa Therapeutics
Cue Biopharma, . vs Gilboa Therapeutics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cue Biopharma, . is on 62/100 and Gilboa Therapeutics on 43/100.
Where each one leads
Cue Biopharma, .
- our overall score: 62/100 against 43/100
- agent readiness: 42/100 against 22/100
- domain rating: 34/100 against 4/100
- headcount: 38 against 2
- LinkedIn following: 5,297 against 956
Gilboa Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Cue Biopharma, . | Gilboa Therapeutics |
|---|---|---|
| What it is | Developing engineered biologics to harness the immune system for disease treatment. | Preclinical biopharma developing next-gen cancer immunotherapies using proprietary SolidT technology. |
| Category | Biotech, Drug Discovery, Immunotherapy, Therapeutics | Biopharmaceuticals, Immunotherapy, Cancer Treatment, Biotechnology |
| Sells toBusiness model | B2B | B2G |
| Offering | Biotech | Hardware |
| Founded | 2017 | 2017 |
| Headquarters | Boston, United States | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Cue Biopharma, . | Gilboa Therapeutics |
|---|---|---|
| Employees | 38 | 2 |
| Headcount growthLast 12 months | Not published | -49.5% |
| Total funding | $10.0M | Not published |
| Latest round | Seed | Not published |
| LinkedIn followers | 5,297 | 956 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cue Biopharma, . | Gilboa Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 43/100 |
| Traction | Not published | 11/100 |
| Team | 60/100 | Not published |
| Search visibility | 67/100 | 54/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 34/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cue Biopharma, . | Gilboa Therapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Tailwind CSS | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Cue Biopharma, . vs Gilboa Therapeutics: common questions
Which is better, Cue Biopharma, . or Gilboa Therapeutics?
On our 0-100 score Cue Biopharma, . rates higher (62/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Cue Biopharma, . and Gilboa Therapeutics compare on the numbers?
Cue Biopharma, . leads on our overall score (62/100 against 43/100), agent readiness (42/100 against 22/100), domain rating (34/100 against 4/100), headcount (38 against 2), LinkedIn following (5,297 against 956).
Read the full Cue Biopharma, . review and pricing or the Gilboa Therapeutics review and pricing. You can also browse other Cue Biopharma, . alternatives we track.